A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease - Concepedia

Concepedia

Publication | Open Access

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

DOI Full Paper Access

252

Citations

34

References

2011

Year

Stephen Salloway, Reisa A. Sperling, Ron Keren, Anton P. Porsteinsson, C H van Dyck, Pierre N. Tariot, S. Gilman, Douglas L. Arnold, Susan Abushakra, C. Hernandez,

Abstract

Due to the small sample sizes, this Class II trial provides insufficient evidence to support or refute a benefit of ELND005.

References

	Year	Citations

Page 1